Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-apus
/
Apimeds Pharmaceuticals US Inc
APUS
1.609
USD
-0.131
-7.53%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
12.72M
Market Cap
Loss
P/E TTM
Apimeds Pharmaceuticals US Inc
1.609
-0.131
-7.53%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
Total equity
Cash, cash equivalents and short-term investments
69.86%
250.34K
-99.16%
3.46K
-96.46%
26.57K
--
63.33K
--
147.38K
--
410.48K
--
751.05K
- Cash and cash equivalents
69.86%
250.34K
-99.16%
3.46K
-96.46%
26.57K
--
63.33K
--
147.38K
--
410.48K
--
751.05K
Prepaid expenses
-7.50%
9.56K
-17.19%
9.60K
-93.98%
10.34K
--
10.34K
--
10.34K
--
11.60K
--
171.67K
Total current assets
64.79%
259.90K
-96.91%
13.06K
-96.00%
36.91K
--
73.66K
--
157.72K
--
422.08K
--
922.73K
Non-current assets
Total assets
64.79%
259.90K
-96.91%
13.06K
-96.00%
36.91K
--
73.66K
--
157.72K
--
422.08K
--
922.73K
Liabilities
Current liabilities
-Other payables
175.40%
211.60K
--
183.14K
--
--
--
85.34K
--
76.83K
--
0.00
--
55.00K
Accrued expenses
1467.97%
935.20K
--
591.19K
--
--
--
302.83K
--
59.64K
--
--
--
--
Short-term debt and lease liabilities
--
623.62K
--
250.00K
-3.85%
250.00K
--
100.00K
--
--
--
0.00
--
260.00K
-Short-term debt
--
373.62K
--
--
--
--
--
--
--
--
--
--
--
--
Other current liabilities
175.40%
211.60K
--
183.14K
--
--
--
85.34K
--
76.83K
--
0.00
--
55.00K
Total current liabilities
1197.23%
1.77M
730.67%
1.02M
101.93%
761.40K
--
488.17K
--
136.48K
--
123.31K
--
377.07K
Non-current liabilities
Long-term debt and lease liabilities
-12.54%
250.00K
29.96%
346.84K
-19.50%
321.99K
--
299.46K
--
285.84K
--
266.89K
--
400.00K
-Long-term debt
-12.54%
250.00K
29.96%
346.84K
-19.50%
321.99K
--
299.46K
--
285.84K
--
266.89K
--
400.00K
Total non-current liabilities
-12.54%
250.00K
29.96%
346.84K
-19.50%
321.99K
--
299.46K
--
285.84K
--
266.89K
--
400.00K
Total liabilities
378.41%
2.02M
251.40%
1.37M
39.42%
1.08M
--
787.63K
--
422.32K
--
390.20K
--
777.07K
Shareholders' equity
Common equity
-0.00%
3.03M
-0.00%
3.03M
17.56%
3.03M
--
3.03M
--
3.03M
--
3.03M
--
2.58M
Retained earnings
-45.35%
-4.79M
-46.30%
-4.39M
-67.57%
-4.08M
--
-3.75M
--
-3.30M
--
-3.00M
--
-2.43M
Capital reserves
4.47%
2.95M
4.47%
2.95M
46.50%
2.83M
--
2.83M
--
2.83M
--
2.83M
--
1.93M
Total equity
-565.35%
-1.76M
-4361.31%
-1.36M
-818.45%
-1.05M
--
-713.97K
--
-264.60K
--
31.87K
--
145.66K
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up